Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Cantón, , Urbano,
DOB: 01-APR-1945 (Age: 80)
Gender: male
Address:
Vial Vito Trujillo 29 Piso 2
38001 Santa Cruz de Tenerife (Spain)
ID: 8854-480268-4 (ECI)
Report
Date: 22-SEP-2020
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Centro de Salud Ruiz de Padrón
(Spain)
Specimen
Collected: 22-SEP-2020

Chemistry

Test 22-SEP-2020 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.4 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 74.6 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 11.3 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.6 L 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.7 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 140.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.3 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 109.0 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 25.4 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 307.8 H 100 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 113.3 45 - 175 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 228.0 H 0 - 190 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 57.2 40 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 13.0 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Most parameters are within normal limits. Notable findings include mildly decreased creatinine, likely reflecting low muscle mass in an elderly patient, and significantly elevated total and LDL cholesterol, indicating increased cardiovascular risk. Glucose control is adequate. Renal function and electrolytes are normal. Recommend addressing hypercholesterolemia and monitoring cardiovascular risk factors.